What is the appropriate management plan for a scleral abrasion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Scleral Abrasion

Immediate Treatment Protocol

For a scleral scratch or abrasion, initiate topical broad-spectrum antibiotic drops within 24 hours to prevent secondary bacterial infection, with fluoroquinolones (moxifloxacin 0.5% or gatifloxacin 0.5%) as the preferred first-line agents applied four times daily until complete healing is confirmed. 1, 2, 3

The American Academy of Ophthalmology emphasizes that prophylactic antibiotics are most effective when started within this 24-hour window, specifically preventing progression to ulceration and bacterial keratitis. 1, 2, 3

Antibiotic Selection Strategy

  • Fluoroquinolones are the preferred choice because they achieve superior tissue penetration in both corneal and scleral tissue and provide broad-spectrum coverage against gram-positive and gram-negative organisms. 2, 4, 3

  • The antibiotic selection must account for normal conjunctival and skin flora, the patient's immune status, and underlying conditions such as diabetes or Parkinson's disease that impair healing. 1, 4

  • Add antibiotic ointment at bedtime for additional lubrication and sustained antimicrobial coverage during sleep when blinking is absent. 2, 4, 3

Pain Management

  • Prescribe oral acetaminophen or NSAIDs for residual discomfort rather than relying on topical anesthetics. 2, 3

  • A short course of topical NSAID drops can control discomfort, but close follow-up is mandatory due to risk of corneal melting or perforation with prolonged topical NSAID use. 1

  • Consider a cycloplegic agent (such as cyclopentolate or homatropine) if substantial anterior chamber inflammation develops to decrease synechiae formation and reduce pain. 1, 2

Critical Management Principles: What NOT to Do

Never patch the eye - multiple high-quality studies demonstrate that patching does not improve pain or healing speed and may actually delay epithelialization, particularly increasing infection risk in contact lens wearers. 1, 4, 3, 5, 6

Avoid topical corticosteroids initially as they delay healing and increase infection risk. 1, 4, 3 Steroids should only be considered after 2-3 days of antibiotic-only therapy if bacterial infection is controlled, and never in suspected Acanthamoeba, Nocardia, or fungal infections where they worsen outcomes. 2, 3

Do not use combination steroid-antibiotic drops as initial therapy. 2, 3

Instruct the patient not to rub the eye as this worsens the injury and causes further tissue damage. 2, 4

High-Risk Scenarios Requiring Enhanced Vigilance

Contact Lens-Related Injuries

  • Mandatory antipseudomonal fluoroquinolone coverage is required due to dramatically increased Pseudomonas keratitis risk. 2, 3
  • Never patch the eye in contact lens wearers - this increases bacterial keratitis risk substantially. 1, 2, 3
  • Advise complete avoidance of contact lens wear until healing is confirmed by examination. 2, 3

Other High-Risk Populations

  • Prior scleral or corneal surgery (refractive, cataract, glaucoma surgery, keratoplasty) significantly increases infection risk. 2, 3
  • Chronic ocular surface disease (severe dry eye, lagophthalmos, entropion) requires enhanced monitoring. 2, 3
  • Immunosuppression or diabetes impairs healing and increases infection susceptibility. 1, 2, 3

Follow-Up Protocol

  • Re-evaluate within 24 hours to assess healing progress and detect early signs of infection. 2, 3

  • Regular follow-up is necessary to monitor for complications, particularly in high-risk patients. 2, 3

  • Assess adequate blinking during waking hours and complete eyelid closure during sleep, as these are critical for healing. 1, 4, 3

Red Flags Requiring Immediate Ophthalmology Referral

Obtain emergent ophthalmology consultation for:

  • Scleral involvement with deep stromal extension or melting 1, 3
  • Central infiltrate greater than 2 mm 2, 3
  • Corneal or scleral infiltrate with suppuration, necrosis, or feathery margins suggesting bacterial keratitis 2, 3
  • High-velocity eye injuries or penetrating trauma 2, 3
  • Irregular pupil after trauma 2, 3
  • Eye bleeding or acute vision loss 2, 3
  • Increasing pain, purulent discharge, or vision changes despite treatment 2, 4, 3
  • Impending scleral perforation or descemetocele formation 1

Treatment Escalation for Severe Cases

If the abrasion progresses to bacterial keratitis with scleral extension:

  • Obtain cultures before initiating treatment for central infiltrates greater than 2 mm or significant stromal involvement. 1, 2, 3

  • Initiate loading dose of antibiotics every 5-15 minutes, then hourly dosing. 1, 2, 3

  • Consider fortified antibiotics (tobramycin 1.5% plus cefazolin 10%) prepared by an FDA-designated compounding pharmacy for severe cases with scleral spread. 1, 2, 3

  • Subconjunctival antibiotics may be helpful where there is imminent scleral spread or perforation, or when adherence to the treatment regimen is questionable. 1

  • Systemic antibiotic therapy is indicated for cases of scleral or intraocular extension of infection. 1

Management of Impaired Healing

Assess Eyelid Function

  • Inadequate blinking or incomplete eyelid closure during sleep significantly impairs healing and must be evaluated in all cases. 1, 4, 3

Interventions for Persistent Defects

  • Temporary tarsorrhaphy with botulinum toxin or suture can be employed when blinking or eyelid closure is inadequate. 1, 4, 3

  • Bandage contact lens may be helpful in cases of delayed healing but is generally not needed for simple abrasions. 1, 4, 3

  • Amniotic membrane (as onlay protective flap or inlay tissue substitute) should be considered for persistent epithelial defects unresponsive to standard treatment. 1, 4, 3

Advanced Therapies for Refractory Cases

  • Autologous serum, cord blood tears, or platelet-rich plasma have demonstrated beneficial effects for persistent defects. 1

  • Oral doxycycline has been shown to inhibit matrix metalloproteinases and may help manage persistent defects. 1, 4

Structural Support for Scleral Thinning

If progressive scleral thinning or small perforation develops:

  • Tissue adhesive (cyanoacrylate) may be applied to a small area of marked thinning, which can remain in place for 6 weeks or longer if applied to a clean and compact base. 1

  • The base of the defect needs to be dry for the adhesive to adhere properly. 1

  • Apply the least amount of glue that will seal or support the defect. 1

  • Bandage contact lenses are applied to prevent dislocation of the glue and provide comfort. 1

  • Note that tissue adhesive has not been FDA-approved for ocular use but has been widely used internationally; use a sterile product to reduce infection risk. 1

  • Fibrin glue should not be used with scleral perforations because it biodegrades rapidly before healing can occur. 1

Important Caveats

  • Chronic prophylactic antibiotic use promotes resistant organisms and should only be used for finite treatment periods during the healing phase. 1, 2, 3

  • Increasing resistance of MRSA and Pseudomonas to fluoroquinolones has been documented, highlighting the need for judicious antibiotic use. 1, 2

  • Patient education is essential: instruct on infection warning signs (increasing pain, discharge, vision changes) and the need for prompt ophthalmologic care if these develop. 1, 2, 3

  • Topical corticosteroids may be used to reduce intraocular and scleral inflammation in established cases, but intraocular pressure and cataract formation must be monitored with long-term use. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Tetracycline Eye Ointment for Corneal Abrasion Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Corneal Abrasion Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Corneal Abrasion Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Management of corneal abrasions.

American family physician, 2004

Research

Patching for corneal abrasion.

The Cochrane database of systematic reviews, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.